Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 73

Results For "API"

3145 News Found

Datavant partners with Indegene to power clinical trial recruitment
Digitisation | September 21, 2025

Datavant partners with Indegene to power clinical trial recruitment

Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials


Roche to acquire 89bio in $3.5B deal
News | September 20, 2025

Roche to acquire 89bio in $3.5B deal

Pegozafermin offers a distinct mechanism of action with potential for enhanced efficacy and tolerability and opportunities for combination development with incretins


AllRock Bio raises $50 million to drive therapy for pulmonary hypertension into phase 2 trials
Clinical Trials | September 19, 2025

AllRock Bio raises $50 million to drive therapy for pulmonary hypertension into phase 2 trials

Funding supports development of first-in-class pan-ROCK inhibitor ROC-101 through Phase 2a clinical testing


Merck opens €150 million manufacturing facility in Ireland
News | September 19, 2025

Merck opens €150 million manufacturing facility in Ireland

Merck opens first climate-neutral manufacturing facility in Ireland


AstraZeneca's Saphnelo succeeds in Phase III as self-injectable lupus treatment
Clinical Trials | September 18, 2025

AstraZeneca's Saphnelo succeeds in Phase III as self-injectable lupus treatment

The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo


Bayer inaugurates new phytomedicines lab facility
News | September 18, 2025

Bayer inaugurates new phytomedicines lab facility

The lab will facilitate the development of herbal and natural-based solutions


Bayer launches biotech innovation platform in China
Startup | September 17, 2025

Bayer launches biotech innovation platform in China

Bayer Co.Lab AdVenture platform will accelerate biotech innovation through global investment networks


Pete Pharma and FABRX announce strategic partnership
News | September 17, 2025

Pete Pharma and FABRX announce strategic partnership

Pete Pharma will leverage FABRX’s extensive foundation of scientific validation to deliver a commercially viable, pharmacy-ready solution in the US


GSK to invest $30 billion in R&D, manufacturing in US over next 5 years
News | September 17, 2025

GSK to invest $30 billion in R&D, manufacturing in US over next 5 years

Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs